Safflower polysaccharide ameliorates acute ulcerative colitis by regulating STAT3/NF-κB signaling pathways and repairing intestinal barrier function

Biomed Pharmacother. 2024 May:174:116553. doi: 10.1016/j.biopha.2024.116553. Epub 2024 Apr 8.

Abstract

This study is to investigate the effect of SPS on the UC model. An animal model of UC induced by DSS was developed using C57BL/6 mice. The body weight was recorded every day, and the symptoms related to UC were detected. H&E staining, AB-PAS staining and PSR staining were used to evaluate the histopathological changes of the colon. Inflammation and mucosal barrier indicators were detected by qRT-PCR, and the 16 S rRNA sequence was used to detect the intestinal flora. SPS can significantly prevent and treat DSS-induced ulcerative colitis in animals. SPS significantly improved clinical symptoms, alleviated pathological damage, inhibited the infiltration of intestinal inflammatory cells. SPS treatment can protect goblet cells, enhance the expression of tight junction proteins and mucins, inhibit the expression of antimicrobial peptides, thereby improving intestinal barrier integrity. The prevention and treatment mechanism of SPS may be related to the inhibition of STAT3/NF-κB signaling pathway to regulate intestinal barrier function. In particular, SPS also significantly adjusted the structure of intestinal flora, significantly increasing the abundance of Akkermansia and Limosilactobacillus and inhibiting the abundance of Bacteroides. Overall, SPS has a significant therapeutic effect on ulcerative colitis mice, and is expected to play its value effectively in clinical treatment.

Keywords: Inflammation; Intestinal barrier; Intestinal flora; Safflower polysaccharide; Ulcerative colitis.

MeSH terms

  • Animals
  • Colitis, Ulcerative* / drug therapy
  • Colitis, Ulcerative* / metabolism
  • Colitis, Ulcerative* / microbiology
  • Colitis, Ulcerative* / pathology
  • Colon / drug effects
  • Colon / metabolism
  • Colon / pathology
  • Dextran Sulfate
  • Disease Models, Animal
  • Gastrointestinal Microbiome* / drug effects
  • Intestinal Barrier Function
  • Intestinal Mucosa* / drug effects
  • Intestinal Mucosa* / metabolism
  • Intestinal Mucosa* / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL*
  • NF-kappa B* / metabolism
  • Polysaccharides* / isolation & purification
  • Polysaccharides* / pharmacology
  • STAT3 Transcription Factor* / metabolism
  • Signal Transduction* / drug effects

Substances

  • STAT3 Transcription Factor
  • NF-kappa B
  • Polysaccharides
  • Dextran Sulfate
  • Stat3 protein, mouse